Jayson Bedford
Stock Analyst at Raymond James
(4.67)
# 824
Out of 4,673 analysts
732
Total ratings
60.2%
Success rate
8.9%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICUI ICU Medical | Maintained: Buy | $180 → $200 | $182.84 | +9.39% | 60 | Aug 7, 2026 | |
| TFX Teleflex | Maintained: Buy | $150 → $155 | $138.83 | +11.65% | 14 | Aug 7, 2026 | |
| DXCM DexCom | Maintained: Buy | $91 → $94 | $92.34 | +1.80% | 76 | Jul 31, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $83 → $100 | $90.78 | +10.16% | 46 | Jul 31, 2026 | |
| SYK Stryker | Maintained: Buy | $418 → $370 | $329.45 | +12.31% | 5 | Jul 31, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | n/a | $116.64 | - | 85 | Jul 17, 2026 | |
| ISRG Intuitive Surgical | Maintained: Buy | $603 → $483 | $378.81 | +27.50% | 16 | Jul 17, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $209 → $265 | $270.24 | -1.94% | 69 | Jul 16, 2026 | |
| PODD Insulet | Maintained: Buy | $263 → $216 | $148.16 | +45.79% | 46 | Jun 8, 2026 | |
| AXGN Axogen | Maintained: Buy | $41 → $48 | $50.40 | -4.76% | 8 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $124 → $88 | $50.37 | +74.71% | 76 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $100.98 | - | 9 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 | $89.79 | +6.92% | 30 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $24.20 | -21.49% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $93.35 | n/a | 29 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $9.71 | n/a | 26 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $26.34 | n/a | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.74 | n/a | 29 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $192.00 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.74 | n/a | 16 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $22.32 | n/a | 17 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $15.75 | n/a | 41 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 12 | Jul 23, 2019 |
ICU Medical
Aug 7, 2026
Maintained: Buy
Price Target: $180 → $200
Current: $182.84
Upside: +9.39%
Teleflex
Aug 7, 2026
Maintained: Buy
Price Target: $150 → $155
Current: $138.83
Upside: +11.65%
DexCom
Jul 31, 2026
Maintained: Buy
Price Target: $91 → $94
Current: $92.34
Upside: +1.80%
Merit Medical Systems
Jul 31, 2026
Maintained: Buy
Price Target: $83 → $100
Current: $90.78
Upside: +10.16%
Stryker
Jul 31, 2026
Maintained: Buy
Price Target: $418 → $370
Current: $329.45
Upside: +12.31%
Abbott Laboratories
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $116.64
Upside: -
Intuitive Surgical
Jul 17, 2026
Maintained: Buy
Price Target: $603 → $483
Current: $378.81
Upside: +27.50%
Johnson & Johnson
Jul 16, 2026
Maintained: Buy
Price Target: $209 → $265
Current: $270.24
Upside: -1.94%
Insulet
Jun 8, 2026
Maintained: Buy
Price Target: $263 → $216
Current: $148.16
Upside: +45.79%
Axogen
Apr 29, 2026
Maintained: Buy
Price Target: $41 → $48
Current: $50.40
Upside: -4.76%
Mar 27, 2026
Maintained: Buy
Price Target: $124 → $88
Current: $50.37
Upside: +74.71%
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $100.98
Upside: -
Nov 3, 2025
Upgraded: Buy
Price Target: $96
Current: $89.79
Upside: +6.92%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $24.20
Upside: -21.49%
Aug 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $93.35
Upside: n/a
Aug 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $9.71
Upside: n/a
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $26.34
Upside: n/a
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $16.74
Upside: n/a
May 2, 2025
Downgraded: Hold
Price Target: n/a
Current: $192.00
Upside: n/a
Nov 16, 2023
Downgraded: Hold
Price Target: n/a
Current: $14.74
Upside: n/a
May 4, 2023
Maintained: Hold
Price Target: n/a
Current: $22.32
Upside: n/a
Apr 17, 2023
Maintained: Buy
Price Target: $14 → $13
Current: $15.75
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a